SOCS2 and central nervous system cancer: METTL3 also exerts a similar function in glioma to inhibit M1 polarization by promoting m6A methylation of suppressor of cytokine signaling 2 (SOCS2) and reducing its expression, which is a negative regulator of the JAK/STAT pathway (47, 48).